137 related articles for article (PubMed ID: 28807607)
41. Influenza vaccination following liver transplantation in children.
Mack DR; Chartrand SA; Ruby EI; Antonson DL; Shaw BW; Heffron TG
Liver Transpl Surg; 1996 Nov; 2(6):431-7. PubMed ID: 9346689
[TBL] [Abstract][Full Text] [Related]
42. Safety and Immunogenicity of a Recombinant Influenza Vaccine: A Randomized Trial.
Dunkle LM; Izikson R; Patriarca PA; Goldenthal KL; Cox M; Treanor JJ
Pediatrics; 2018 May; 141(5):. PubMed ID: 29610401
[TBL] [Abstract][Full Text] [Related]
43. Clinical reactions and antibody responses to influenza vaccines. A comparison of split or subunit vaccines in children and young adults.
Bernstein DI; Cherry JD
Am J Dis Child; 1983 Jul; 137(7):622-6. PubMed ID: 6858973
[TBL] [Abstract][Full Text] [Related]
44. Pneumococcal conjugate vaccination in toddlers: mucosal antibody response measured as circulating antibody-secreting cells and as salivary antibodies.
Nieminen T; Käyhty H; Leroy O; Eskola J
Pediatr Infect Dis J; 1999 Sep; 18(9):764-72. PubMed ID: 10493335
[TBL] [Abstract][Full Text] [Related]
45. Half- vs full-dose trivalent inactivated influenza vaccine (2004-2005): age, dose, and sex effects on immune responses.
Engler RJ; Nelson MR; Klote MM; VanRaden MJ; Huang CY; Cox NJ; Klimov A; Keitel WA; Nichol KL; Carr WW; Treanor JJ;
Arch Intern Med; 2008 Dec; 168(22):2405-14. PubMed ID: 19064822
[TBL] [Abstract][Full Text] [Related]
46. Total and Envelope Protein-Specific Antibody-Secreting Cell Response in Pediatric Dengue Is Highly Modulated by Age and Subsequent Infections.
Toro JF; Salgado DM; Vega R; Rodríguez JA; Rodríguez LS; Angel J; Franco MA; Greenberg HB; Narváez CF
PLoS One; 2016; 11(8):e0161795. PubMed ID: 27560782
[TBL] [Abstract][Full Text] [Related]
47. [Safety and immunogenicity of seasonal inactivated influenza vaccine (split virion) and cross-reactive antibody responses to the H7N9 avian influenza virus].
Guo W; Xu J; Wu J; Zhao S; He H; Shi W; Yu D; Li J; Gao H; Chen J
Zhonghua Liu Xing Bing Xue Za Zhi; 2014 Aug; 35(8):949-52. PubMed ID: 25376689
[TBL] [Abstract][Full Text] [Related]
48. A non-living nasal influenza vaccine can induce major humoral and cellular immune responses in humans without the need for adjuvants.
Samdal HH; Bakke H; Oftung F; Holst J; Haugen IL; Korsvold GE; Kristoffersen AC; Krogh G; Nord K; Rappuoli R; Berstad AK; Haneberg B
Hum Vaccin; 2005; 1(2):85-90. PubMed ID: 17038826
[TBL] [Abstract][Full Text] [Related]
49. Safety and immunogenicity of a live-attenuated influenza vaccine blended and filled at two manufacturing facilities.
Nolan T; Lee MS; Cordova JM; Cho I; Walker RE; August MJ; Larson S; Coelingh KL; Mendelman PM
Vaccine; 2003 Mar; 21(11-12):1224-31. PubMed ID: 12559802
[TBL] [Abstract][Full Text] [Related]
50. Impact of age and pre-existing influenza immune responses in humans receiving split inactivated influenza vaccine on the induction of the breadth of antibodies to influenza A strains.
Nuñez IA; Carlock MA; Allen JD; Owino SO; Moehling KK; Nowalk P; Susick M; Diagle K; Sweeney K; Mundle S; Vogel TU; Delagrave S; Ramgopal M; Zimmerman RK; Kleanthous H; Ross TM
PLoS One; 2017; 12(11):e0185666. PubMed ID: 29091724
[TBL] [Abstract][Full Text] [Related]
51. Efficacy, immunogenicity and safety of heptavalent pneumococcal conjugate vaccine in low birth weight and preterm infants.
Shinefield H; Black S; Ray P; Fireman B; Schwalbe J; Lewis E
Pediatr Infect Dis J; 2002 Mar; 21(3):182-6. PubMed ID: 12005078
[TBL] [Abstract][Full Text] [Related]
52. Influenza vaccination of pregnant women and protection of their infants.
Madhi SA; Cutland CL; Kuwanda L; Weinberg A; Hugo A; Jones S; Adrian PV; van Niekerk N; Treurnicht F; Ortiz JR; Venter M; Violari A; Neuzil KM; Simões EA; Klugman KP; Nunes MC;
N Engl J Med; 2014 Sep; 371(10):918-31. PubMed ID: 25184864
[TBL] [Abstract][Full Text] [Related]
53. Antibody but not memory B-cell responses are tuned-down in vertically HIV-1 infected children and young individuals being vaccinated yearly against influenza.
Rinaldi S; Zangari P; Cotugno N; Manno EC; Brolatti N; Castrucci MR; Donatelli I; Rossi P; Palma P; Cagigi A
Vaccine; 2014 Feb; 32(6):657-63. PubMed ID: 24333344
[TBL] [Abstract][Full Text] [Related]
54. A dose-response evaluation of inactivated influenza vaccine given intranasally and intramuscularly to healthy young adults.
Atmar RL; Keitel WA; Cate TR; Munoz FM; Ruben F; Couch RB
Vaccine; 2007 Jul; 25(29):5367-73. PubMed ID: 17559990
[TBL] [Abstract][Full Text] [Related]
55. Safety and Immunogenicity of Full-Dose Trivalent Inactivated Influenza Vaccine (TIV) Compared With Half-Dose TIV Administered to Children 6 Through 35 Months of Age.
Halasa NB; Gerber MA; Berry AA; Anderson EL; Winokur P; Keyserling H; Eckard AR; Hill H; Wolff MC; McNeal MM; Edwards KM; Bernstein DI
J Pediatric Infect Dis Soc; 2015 Sep; 4(3):214-24. PubMed ID: 26334249
[TBL] [Abstract][Full Text] [Related]
56. Phase II trial in adults of concurrent or sequential 2009 pandemic H1N1 and 2009-2010 seasonal trivalent influenza vaccinations.
Frey SE; Bernstein DI; Brady RC; Keitel WA; El Sahly H; Rouphael NG; Mulligan MJ; Atmar RL; Edupuganti S; Patel SM; Dickey M; Graham I; Anderson EL; Noah DL; Hill H; Wolff M; Belshe RB
Vaccine; 2015 Jan; 33(1):163-73. PubMed ID: 25444805
[TBL] [Abstract][Full Text] [Related]
57. Safety and immunogenicity of a quadrivalent inactivated influenza vaccine compared to licensed trivalent inactivated influenza vaccines in adults.
Greenberg DP; Robertson CA; Noss MJ; Blatter MM; Biedenbender R; Decker MD
Vaccine; 2013 Jan; 31(5):770-6. PubMed ID: 23228813
[TBL] [Abstract][Full Text] [Related]
58. Immunogenicity and safety of intradermal versus intramuscular route of influenza immunization in infants less than 6 months of age: a randomized controlled trial.
Chiu SS; Chan KH; Tu W; Lau YL; Peiris JS
Vaccine; 2009 Jul; 27(35):4834-9. PubMed ID: 19523908
[TBL] [Abstract][Full Text] [Related]
59. Influenza hemagglutination-inhibition antibody titer as a correlate of vaccine-induced protection.
Ohmit SE; Petrie JG; Cross RT; Johnson E; Monto AS
J Infect Dis; 2011 Dec; 204(12):1879-85. PubMed ID: 21998477
[TBL] [Abstract][Full Text] [Related]
60. DNA vaccine priming for seasonal influenza vaccine in children and adolescents 6 to 17 years of age: A phase 1 randomized clinical trial.
Houser KV; Yamshchikov GV; Bellamy AR; May J; Enama ME; Sarwar U; Larkin B; Bailer RT; Koup R; Paskel M; Subbarao K; Anderson E; Bernstein DI; Creech B; Keyserling H; Spearman P; Wright PF; Graham BS; Ledgerwood JE;
PLoS One; 2018; 13(11):e0206837. PubMed ID: 30388160
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
